Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib

Ingolf Griebsch* (Corresponding Author), Michael Palmer, Peter M. Fayers, Stuart Ellis

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)
9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences